Novo Nordisk and Septerna Collaborate on $2.2 Billion Obesity and Diabetes Drug Deal

Retrieved on: 2025-05-14 13:48:40

Tags for this article:

Click the tags to see associated articles and topics

Novo Nordisk and Septerna Collaborate on $2.2 Billion Obesity and Diabetes Drug Deal. View article details on hiswai:

Excerpt

According to LSEG data, Goldman Sachs holds a 3.3% stake in Septerna, while Third Rock Ventures owns 23.7%. Source: IndexBox Market Intelligence ...

Article found on: www.indexbox.io